Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Arthritis Research & Therapy

Figure 1

From: Tumor necrosis factor inhibitor therapy but not standard therapy is associated with resolution of erosion in the sacroiliac joints of patients with axial spondyloarthritis

Figure 1

Patients with axial spondyloarthritis demonstrating any change (increase or decrease) in Sacroiliac Joint Structural Scores for fat metaplasia or erosion. Percentage of patients with axial spondyloarthritis who demonstrate any change (increase or decrease) in Spondyloarthritis Research Consortium of Canada magnetic resonance imaging Sacroiliac Joint Structural Scores for fat metaplasia or erosion after 2 years on either standard therapy (nonsteroidal anti-inflammatory drug and/or physiotherapy, n = 68) or tumor necrosis factor alpha (TNFα) inhibitor therapy (n = 79).

Back to article page